Assessment of muscle relaxation by rocuronium: A comparison of compressomyography with electromyography neuromuscular monitoring

Assessment of muscle relaxation by rocuronium: A comparison of compressomyography with electromyography neuromuscular monitoring - A comparison of compressomyography with electromyography neuromuscular monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045930

Enrollment

Registered

2021-10-31

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing surgery under general anesthesia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing surgery under general anesthesia using rocuronium as neuromuscular blocking agent ASA physical status1-3 Patients with a low need for additional muscle relaxants

Exclusion criteria

Exclusion criteria: Patients whose surgical site is upper limb Patients who are allergic to the drugs or ingredients used in this study Obesity patients with BMI 30 or more and low body weight patients below 18.5 Patients with neuromuscular disease or paralysis Patients with significant liver dysfunction or renal dysfunction Patient who has cardiac pacemaker, implantable cardioverter defibrillator (ICD) in place Pregnant women, patients who may be pregnant Others who judged that the research director is inappropriate as the research subject

Design outcomes

Primary

Measure	Time frame
Time from rocuronium administration to TOF ratio 0.9 or higher	—

Countries

Japan

Contacts

Public ContactKatsuyuki Yamagata

Tokyo Metropolitan Health and Hospitals Corporation Ohkubo Hospital Department of Anesthesiology

katsuyuki_yamagata@tokyo-hmt.jp03-5273-7711

Outcome results